SKI Market

Indian Indices

Nifty

24,426.85 -74.05
(-0.30%)

Sensex

79,809.65 -270.92
( -0.34%)

Bank Nifty

53,655.65 -164.70
( -0.31%)

Nifty IT

35,181.25 -307.50
( -0.87%)

Global Indices

Nasdaq

45,661.67 75.43
(0.17%)

Dow Jones

6,523.31 20.91
(0.32%)

Hang Seng

42,764.54 -64.25
(-0.15%)

Nikkei 225

9,187.34 -29.48
(-0.32%)

Forex

USD-INR

87.60 -0.05
(-0.06%)

EUR-INR

102.16 0.14
(0.13%)

GBP-INR

118.33 0.25
(0.21%)

JPY-INR

0.60 0.00
(0.24%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Syncom Formulations (India) Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524470

INE312C01025

3.6159574

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SYNCOMF

27.77

1592.36

EPS(TTM)

Face Value()

Div & Yield %

0.61

Particulars(INCOME)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)	Mar 2019 ( Cr)
Sales Turnover	258.36	224.64	219.66	244.81	205.51	186.77
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	258.36	224.64	219.66	244.81	205.51	186.77
Other Income	13.10	14.62	12.02	7.17	5.22	5.08
Stock Adjustments	2.18	-0.05	-3.32	4.05	3.70	1.01
Total Income	273.64	239.21	228.36	256.03	214.43	192.86
EXPENDITURE :
Raw Materials	157.74	142.07	137.23	165.51	155.32	136.66
Power & Fuel Cost	6.13	5.31	4.38	3.84	3.93	3.63
Employee Cost	33.57	24.44	20.73	18.24	15.80	15.21
Other Manufacturing Expenses	2.39	3.19	2.26	2.09	2.02	1.72
Selling & Administrative Expenses	29.62	27.29	29.71	19.79	13.76	16.90
Miscellaneous Expenses	3.03	2.41	2.00	1.34	1.65	1.82
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	232.47	204.71	196.32	210.81	192.47	175.94
Operating Profit	41.18	34.51	32.05	45.22	21.96	16.93
Interest	4.70	3.40	1.93	0.48	0.61	0.25
Gross Profit	36.48	31.11	30.12	44.74	21.35	16.68
Depreciation	4.72	4.54	3.95	4.03	4.06	4.00
Profit Before Tax	31.76	26.57	26.17	40.71	17.29	12.68
Tax	7.58	6.65	6.25	11.30	4.43	3.44
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.55	-0.15	0.14	0.23	-1.40	-1.86
Reported Net Profit	23.62	20.07	19.79	29.17	14.25	11.09
Extraordinary Items	0.55	0.14	0.03	0.10	-0.04	0.00
Adjusted Net Profit	23.07	19.93	19.76	29.07	14.29	11.09
Adjustment below Net Profit	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance brought forward	79.36	62.11	42.32	13.15	11.40	7.81
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	2.82	0.00	0.00	12.50	7.50
P & L Balance carried down	102.99	79.36	62.11	42.32	13.15	11.40
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	3.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.03	0.00	0.00	0.00
Earnings Per Share-Unit Curr	0.25	0.21	0.23	0.37	0.18	0.14
Earnings Per Share(Adj)-Unit Curr	0.25	0.21	0.23	0.37	0.18	0.14
Book Value-Unit Curr	3.05	2.72	2.52	2.25	1.87	1.70
Book Value(Adj)-Unit Curr	3.05	2.72	2.52	2.25	1.87	1.70

24,426.85 -74.05 (-0.30%)

79,809.65 -270.92 ( -0.34%)

53,655.65 -164.70 ( -0.31%)

35,181.25 -307.50 ( -0.87%)

45,661.67 75.43 (0.17%)

6,523.31 20.91 (0.32%)

42,764.54 -64.25 (-0.15%)

9,187.34 -29.48 (-0.32%)

87.60 -0.05 (-0.06%)

102.16 0.14 (0.13%)

118.33 0.25 (0.21%)

0.60 0.00 (0.24%)